PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Panel Discussion
Panelists:
Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP
Synthetic Biology Workshop 2017 - Panel Discussion
Alec Shkolnik, CoFounder and CEO, LiquidPiston
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Hilton Pryce Lewis, Co-founder, President and CEO, GVD Corporation
Emilio Frazzoli, MIT Professor of Aeronautics & Astronautics, nuTonomy CTO
Josh Adler, Sourcewater Founder & CEO
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
Matthew Osman, Legit